Jay Hunt , PhD
Associate Professor

jdhunt3@yahoo.com

Degrees
Ph.D., University of Tennessee Health Sciences Center, 1990

Research Interests
Lipid second messenger signaling in differentiated vascular endothelial cells associated with tumor-inuduced angiogenesis; molecular epidemiology of cancer

8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer.

Shen J, Deininger P, Hunt JD, Zhao H.
Cancer. 2007 Feb 1;109(3):574-80.

Elevation of serum riboflavin carrier protein in hepatocellular carcinoma.

Rao PN, Crippin J, Levine E, Hunt J, Baliga S, Balart L, Anthony L, Mulekar M, Raj MH.
Hepatol Res. 2006 Jun;35(2):83-7.

:

Abasic sites and survival in resected patients with non-small cell lung cancer.

Zhao H, Shen J, Deininger P, Hunt JD.
Cancer Lett. 2007 Feb 8;246(1-2):47-53.

TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.

Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Taniere P, Brennan P, Boffetta P, Zaridze DG, Hainaut P.
Cancer Res. 2005 Jun 15;65(12):5076-83.

Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies.

Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P.
Int J Cancer. 2005 Mar 10;114(1):101-8.

Platelet-activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration.

Axelrad TW, Deo DD, Ottino P, Van Kirk J, Bazan NG, Bazan HE, Hunt JD.
FASEB J. 2004 Mar;18(3):568-70. Jan 8.